ELOXX PHARMACEUTICALS, INC. (ELOX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $40.00K; Additional Paid in Capital, Common StockUSD $355.22M; Retained Earnings (Accumulated Deficit)USD $-308.84M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $5.00K; Additional Paid in Capital, Common StockUSD $296.75M; Retained Earnings (Accumulated Deficit)USD $-304.33M.
- 2026-03-12: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD (m); Additional Paid in Capital, Common StockUSD (m); Retained Earnings (Accumulated Deficit)USD (m).
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $4.00K; Additional Paid in Capital, Common StockUSD $288.67M; Retained Earnings (Accumulated Deficit)USD $-300.58M.
ELOXX PHARMACEUTICALS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | Adjustments to Additional Paid in Capital, Fair Value USD | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD | APIC, Share-based Payment Arrangement, Recognition and Exercise USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $40.00K | $355.22M | $-308.84M | $46.42M | 3 month · $7.60M | 3 month · $95.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $5.00K | $296.75M | $-304.33M | $-7.58M | 3 month · $9.00K | 3 month · $46.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-12 | (m) | (m) | (m) | (m) | (m) | $100.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $4.00K | $288.67M | $-300.58M | $-11.91M | (m) | 12 month · $235.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | $-27.90M | (m) | 3 month · $16.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) | $-26.02M | (m) | 3 month · $20.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $3.00K | $270.25M | $-294.58M | $-24.34M | (m) | 12 month · $541.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $3.00K | $268.84M | $-291.44M | $-22.60M | 12 month · $262.00K | 12 month · $1.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $31.00K | $268.47M | $-288.55M | $-20.05M | 3 month · $124.00K | 3 month · $418.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $25.00K | $266.38M | $-284.96M | $-18.60M | 3 month · $228.00K | 3 month · $610.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $22.00K | $264.30M | $-280.62M | $16.29M | (m) | 3 month · $597.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $22.00K | $263.71M | $-274.39M | $-10.66M | (m) | 12 month · $3.02M | (m) | $0.00 | (m) | 0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $871.00K | $264.41M | $-268.07M | $-4.98M | 3 month · $263.00K | 3 month · $714.00K | (m) | $2.19M | (m) | 421.37K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $871.00K | $263.69M | $-260.56M | $1.81M | (m) | 3 month · $744.00K | (m) | $2.19M | (m) | 421.37K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $871.00K | $262.95M | $-249.94M | $11.69M | (m) | 3 month · $922.00K | (m) | $2.19M | (m) | 421.37K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $22.00K | $262.88M | $-238.32M | $22.38M | (m) | 12 month · $9.17M | (m) | $2.19M | (m) | 10.54K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $863.00K | $260.43M | $-226.23M | $33.00M | (m) | 3 month · $2.22M | (m) | $2.07M | (m) | 273.15K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $863.00K | $258.19M | $-216.35M | $40.64M | (m) | 3 month · $4.04M | (m) | $2.06M | (m) | 261.59K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $404.00K | $184.56M | $-180.29M | $2.75M | (m) | 3 month · $1.31M | (m) | $1.92M | (m) | 217.62K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $404.00K | $183.25M | $-171.60M | $10.23M | (m) | 12 month · $8.67M | (m) | $1.83M | (m) | 193.74K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $403.00K | $181.97M | $-165.47M | $15.08M | (m) | 3 month · $1.42M | (m) | $1.82M | (m) | 192.65K | (m) | (m) | (m) | 9 month · $400.00K | (m) | (m) |
| 2020-06-30 | (m) | $403.00K | $180.55M | $-158.85M | $20.29M | (m) | 3 month · $1.98M | (m) | $1.82M | $13.00K | 191.62K | (m) | (m) | (m) | 6 month · $400.00K | (m) | (m) |
| 2020-03-31 | (m) | $403.00K | $178.57M | $-150.97M | $26.26M | (m) | 3 month · $4.00M | (m) | $1.82M | $65.00K | 190.58K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $402.00K | $174.51M | $-137.02M | $36.21M | (m) | 12 month · $11.34M | (m) | $1.70M | $18.00K | 155.71K | (m) | (m) | (m) | 12 month · $421.00K | (m) | (m) |
| 2019-09-30 | (m) | $404.00K | $171.78M | $-125.39M | $45.23M | 3 month · $50.00K | 3 month · $2.96M | (m) | $1.58M | $12.00K | 139.53K | (m) | (m) | (m) | 9 month · $400.00K | (m) | (m) |
| 2019-06-30 | (m) | $402.00K | $168.85M | $-112.51M | $55.22M | (m) | 3 month · $3.02M | (m) | $1.54M | $24.00K | 128.70K | (m) | (m) | (m) | 6 month · $400.00K | (m) | (m) |
| 2019-03-31 | (m) | $361.00K | $133.38M | $-98.06M | $34.43M | (m) | 3 month · $2.66M | (m) | $1.25M | $1.00K | 101.89K | (m) | (m) | (m) | 3 month · $421.00K | (m) | (m) |
| 2018-12-31 | (m) | $360.00K | $129.82M | $-86.14M | $42.91M | (m) | 12 month · $13.37M | (m) | $1.13M | (m) | 91.42K | 12 month · $31.00K | (m) | (m) | (m) | (m) | 12 month · $13.37M |
| 2018-09-30 | (m) | $351.00K | $123.31M | $-72.12M | $51.46M | 9 month · $495.00K | 3 month · $2.69M 9 month · $9.61M | (m) | $83.00K | (m) | 8.38K | 9 month · $31.00K | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $349.00K | $120.61M | $-60.96M | $59.92M | 6 month · $495.00K | 3 month · $6.18M 6 month · $6.91M | (m) | $83.00K | (m) | 8.38K | 3 month · $31.00K 6 month · $31.00K | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $274.00K | $60.78M | $-47.55M | $13.51M | (m) | 3 month · $735.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $274.00K | $60.05M | $-38.96M | $21.36M | 12 month · $494.00K | 12 month · $101.00K | (m) | (m) | (m) | 0.00 | (m) | (m) | (m) | (m) | (m) | 12 month · $101.00K |
| 2017-09-30 | (m) | $514.15K | (m) | $-123.21M | $3.31M | (m) | (m) | $126.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $626.00 |
| 2017-06-30 | (m) | $292.03K | (m) | $-121.82M | $871.21K | (m) | (m) | $122.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $285.36K | 12 month · $80.11K |
| 2017-03-31 | (m) | $269.21K | (m) | $-119.45M | $2.58M | (m) | (m) | $121.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $307.77K | 9 month · $79.48K |
| 2016-12-31 | $76.00K | $42.00K | $18.24M | $-17.75M | $610.00K | (m) | (m) | $120.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $5.15K 12 month · $78.00K |
| 2016-09-30 | (m) | $204.96K | (m) | $-116.57M | $3.63M | (m) | (m) | $119.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $8.21K |
| 2016-06-30 | (m) | $204.96K | (m) | $-115.63M | $4.56M | (m) | (m) | $119.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $156.68K |
| 2016-03-31 | (m) | $204.21K | (m) | (m) | $5.64M | (m) | (m) | $119.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $95.01K |
| 2015-12-31 | (m) | $204.21K | (m) | (m) | $643.00K | (m) | (m) | $119.90M | (m) | (m) | (m) | (m) | 12 month · $300.00K | (m) | (m) | (m) | 6 month · $88.83K 12 month · $92.00K |
| 2015-09-30 | (m) | $203.88K | (m) | (m) | $12.51M | (m) | (m) | $119.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $23.48K |
| 2015-06-30 | (m) | $187.53K | (m) | $-107.18M | $12.22M | (m) | (m) | $119.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $480.68K |
| 2015-03-31 | $4.00 | $139.75K | (m) | (m) | $11.21M | (m) | (m) | $116.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $877.57K |
| 2014-12-31 | $6.00 | $138.67K | (m) | (m) | $2.77M | (m) | (m) | $116.04M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $379.17K |
| 2014-09-30 | $6.00 | $138.46K | (m) | (m) | $22.43M | (m) | (m) | $115.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $139.13K |
| 2014-06-30 | $6.00 | $138.46K | (m) | (m) | $27.49M | (m) | (m) | $115.63M | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | 12 month · $861.24K |
| 2014-03-31 | (m) | $68.98K | (m) | (m) | $9.80M | (m) | (m) | $92.63M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $299.99K |
| 2013-12-31 | (m) | $49.57K | (m) | (m) | $7.72M | (m) | (m) | $85.54M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $101.77K |
| 2013-09-30 | (m) | $23.48K | (m) | (m) | $2.12M | (m) | (m) | $78.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $124.47K |
| 2013-06-30 | (m) | $22.72K | (m) | (m) | $3.79M | (m) | (m) | $78.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $724.69K |
| 2013-03-31 | (m) | $1.47M | (m) | (m) | $3.31M | 9 month · $6.39K | (m) | $74.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $-459.00K | (m) |
| 2012-12-31 | (m) | $1.17M | (m) | (m) | $1.58M | 6 month · $-6.39K | (m) | $71.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $350.13K | (m) |
| 2012-09-30 | (m) | $1.17M | (m) | (m) | $2.63M | 3 month · $6.39K | (m) | $71.61M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $153.56K | (m) |
| 2012-06-30 | (m) | $941.12K | (m) | (m) | $3.45M | 12 month · $-143.76K | (m) | $69.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $766.00K | (m) |
| 2012-03-31 | (m) | $918.72K | (m) | (m) | $4.60M | 9 month · $148.38K | (m) | $69.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $609.88K | (m) |
| 2011-12-31 | (m) | $808.64K | (m) | (m) | $2.83M | 6 month · $32.03K | (m) | $66.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $408.03K | (m) |
| 2011-09-30 | (m) | $796.96K | (m) | (m) | $3.93M | 3 month · $30.27K | (m) | $65.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $123.55K | (m) |
| 2011-06-30 | (m) | $777.70K | (m) | (m) | $4.52M | 12 month · $-197.91K | (m) | $64.49M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $866.24K | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | $7.98M | 12 month · $-180.86K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $-1.76M | 12 month · $386.64K | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | $5.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $506.85K | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | $9.84M | 12 month · $9.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $1.54M | (m) |
| 2007-06-30 | (m) | (m) | (m) | (m) | $2.69M | 12 month · $-230.48K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $970.16K | (m) |
| 2006-06-30 | (m) | (m) | (m) | (m) | $2.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $677.00K | (m) |
| 2005-06-30 | (m) | (m) | (m) | (m) | $5.59M | 12 month · $-428.86K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $-1.72M | 12 month · $974.24K | (m) |
| 2004-06-30 | (m) | (m) | (m) | (m) | $4.73M | 12 month · $-378.62K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $-2.10M | 12 month · $1.83M | (m) |
| 2003-06-30 | (m) | (m) | (m) | (m) | $2.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $848.84K | (m) |
| 2002-06-30 | (m) | (m) | (m) | (m) | $4.79M | 12 month · $-846.44K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $1.85M | (m) |
| 2001-06-30 | (m) | (m) | (m) | (m) | $-206.71K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $308.62K | (m) |
| 2000-06-30 | (m) | (m) | (m) | (m) | $1.52M | 12 month · $-260.60K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $1.48M | (m) |
| 1999-06-30 | (m) | (m) | (m) | (m) | $912.17K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 1998-06-30 | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |